In the BioHarmony Drug Report Database
Isoproterenol
Aerolone, Isoproterenol, Isuprel, Norisodrine Aerotrol, Vapo-iso (isoproterenol) is a small molecule pharmaceutical. Isoproterenol was first approved as Aerolone on 1982-01-01. It is used to treat adams-stokes syndrome, bradycardia, heart arrest, hemorrhagic shock, and low cardiac output amongst others in the USA. The pharmaceutical is active against beta-2 adrenergic receptor and beta-1 adrenergic receptor. In addition, it is known to target beta-3 adrenergic receptor.
Trade Name
|
Aerolone, Isoproterenol, Isuprel, Norisodrine Aerotrol, Vapo-iso |
|---|---|
Common Name
|
isoproterenol |
ChEMBL ID
|
CHEMBL434 |
Indication
|
adams-stokes syndrome, bradycardia, heart arrest, hemorrhagic shock, low cardiac output, septic shock, torsades de pointes, ventricular fibrillation |
Drug Class
|
Image (chem structure or protein)